Literature DB >> 24973091

Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.

Ahmad Sharanek1, Pamela Bachour-El Azzi1, Houssein Al-Attrache1, Camille C Savary1, Lydie Humbert2, Dominique Rainteau2, Christiane Guguen-Guillouzo1, André Guillouzo3.   

Abstract

Mechanisms involved in drug-induced cholestasis in humans remain poorly understood. Although cyclosporine A (CsA) and tacrolimus (FK506) share similar immunosuppressive properties, only CsA is known to cause dose-dependent cholestasis. Here, we have investigated the mechanisms implicated in early cholestatic effects of CsA using the differentiated human HepaRG cell line. Inhibition of efflux and uptake of taurocholate was evidenced as early as 15 min and 1 h respectively after addition of 10μM CsA; it peaked at around 2 h and was reversible. These early effects were associated with generation of oxidative stress and deregulation of cPKC pathway. At higher CsA concentrations (≥50μM) alterations of efflux and uptake activities were enhanced and became irreversible, pericanalicular F-actin microfilaments were disorganized and bile canaliculi were constricted. These changes were associated with induction of endoplasmic reticulum stress that preceded generation of oxidative stress. Concentration-dependent changes were observed on total bile acid disposition, which were characterized by an increase and a decrease in culture medium and cells, respectively, after a 24-h treatment with CsA. Accordingly, genes encoding hepatobiliary transporters and bile acid synthesis enzymes were differently deregulated depending on CsA concentration. By contrast, FK506 induced limited effects only at 25-50μM and did not alter bile canaliculi. Our data demonstrate involvement of different concentration-dependent mechanisms in CsA-induced cholestasis and point out a critical role of endoplasmic reticulum stress in the occurrence of the major cholestatic features.
© The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  bile acids; cPKC signaling; endoplasmic reticulum stress; hepatocytes; oxidative stress; tacrolimus; transporters

Mesh:

Substances:

Year:  2014        PMID: 24973091      PMCID: PMC4833109          DOI: 10.1093/toxsci/kfu122

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  33 in total

Review 1.  The bile salt export pump.

Authors:  Bruno Stieger; Yvonne Meier; Peter J Meier
Journal:  Pflugers Arch       Date:  2006-10-19       Impact factor: 3.657

Review 2.  The role of metabolic activation in drug-induced hepatotoxicity.

Authors:  B Kevin Park; Neil R Kitteringham; James L Maggs; Munir Pirmohamed; Dominic P Williams
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

3.  Oxidative stress induces internalization of the bile salt export pump, Bsep, and bile salt secretory failure in isolated rat hepatocyte couplets: a role for protein kinase C and prevention by protein kinase A.

Authors:  Leonardo M Pérez; Piotr Milkiewicz; Elwyn Elias; Roger Coleman; Enrique J Sánchez Pozzi; Marcelo G Roma
Journal:  Toxicol Sci       Date:  2006-02-01       Impact factor: 4.849

4.  Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death.

Authors:  Nicolas Bouvier; Jean Pierre Flinois; Jerome Gilleron; François-Ludovic Sauvage; Christophe Legendre; Philippe Beaune; Eric Thervet; Dany Anglicheau; Nicolas Pallet
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-05

Review 5.  The side-effects of ciclosporine-A and tacrolimus.

Authors:  M J Mihatsch; M Kyo; K Morozumi; Y Yamaguchi; V Nickeleit; B Ryffel
Journal:  Clin Nephrol       Date:  1998-06       Impact factor: 0.975

6.  Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.

Authors:  Virginie Cerec; Denise Glaise; Delphine Garnier; Serban Morosan; Bruno Turlin; Bernard Drenou; Philippe Gripon; Dina Kremsdorf; Christiane Guguen-Guillouzo; Anne Corlu
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

Review 7.  Oxidative stress: a radical way to stop making bile.

Authors:  Marcelo G Roma; Enrique J Sanchez Pozzi
Journal:  Ann Hepatol       Date:  2008 Jan-Mar       Impact factor: 2.400

Review 8.  Mechanisms of cholestasis.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Clin Liver Dis       Date:  2008-02       Impact factor: 6.126

9.  The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response.

Authors:  Sana Basseri; Sárka Lhoták; Arya M Sharma; Richard C Austin
Journal:  J Lipid Res       Date:  2009-12       Impact factor: 5.922

10.  The PXR is a drug target for chronic inflammatory liver disease.

Authors:  Karen Wallace; David E Cowie; Dimitrios K Konstantinou; Stephen J Hill; Torunn E Tjelle; Andrew Axon; Matthew Koruth; Steven A White; Harald Carlsen; Derek A Mann; Matthew C Wright
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-21       Impact factor: 4.292

View more
  18 in total

1.  Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.

Authors:  Benjamin L Woolbright; Mitchell R McGill; Huimin Yan; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-08-13       Impact factor: 4.080

Review 2.  Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Authors:  Richard J Weaver; Eric A Blomme; Amy E Chadwick; Ian M Copple; Helga H J Gerets; Christopher E Goldring; Andre Guillouzo; Philip G Hewitt; Magnus Ingelman-Sundberg; Klaus Gjervig Jensen; Satu Juhila; Ursula Klingmüller; Gilles Labbe; Michael J Liguori; Cerys A Lovatt; Paul Morgan; Dean J Naisbitt; Raymond H H Pieters; Jan Snoeys; Bob van de Water; Dominic P Williams; B Kevin Park
Journal:  Nat Rev Drug Discov       Date:  2019-11-20       Impact factor: 84.694

3.  Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes.

Authors:  Pamela Bachour-El Azzi; Ahmad Sharanek; Audrey Burban; Ruoya Li; Rémy Le Guével; Ziad Abdel-Razzak; Bruno Stieger; Christiane Guguen-Guillouzo; André Guillouzo
Journal:  Toxicol Sci       Date:  2015-02-17       Impact factor: 4.849

4.  ZIP14 is degraded in response to manganese exposure.

Authors:  Khristy J Thompson; Marianne Wessling-Resnick
Journal:  Biometals       Date:  2019-09-20       Impact factor: 2.949

5.  A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Authors:  Anaïs Michaut; Dounia Le Guillou; Caroline Moreau; Simon Bucher; Mitchell R McGill; Sophie Martinais; Thomas Gicquel; Isabelle Morel; Marie-Anne Robin; Hartmut Jaeschke; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

6.  Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.

Authors:  José Vicente Castell; Ramiro Jover; Petar D Petrov; Leonor Fernández-Murga; Isabel Conde; Teresa Martínez-Sena; Carla Guzmán
Journal:  Arch Toxicol       Date:  2020-01-01       Impact factor: 5.153

7.  Cyclosporin A induced toxicity in mouse liver slices is only slightly aggravated by Fxr-deficiency and co-occurs with upregulation of pro-inflammatory genes and downregulation of genes involved in mitochondrial functions.

Authors:  Ewa Szalowska; Tessa E Pronk; Ad Acm Peijnenburg
Journal:  BMC Genomics       Date:  2015-10-20       Impact factor: 3.969

8.  Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs.

Authors:  Ahmad Sharanek; Audrey Burban; Matthew Burbank; Rémy Le Guevel; Ruoya Li; André Guillouzo; Christiane Guguen-Guillouzo
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

9.  Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury.

Authors:  Lindsey Devisscher; Mathieu Vinken; Eva Gijbels; Vânia Vilas-Boas; Pieter Annaert; Tamara Vanhaecke
Journal:  Arch Toxicol       Date:  2020-03-10       Impact factor: 5.153

10.  The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line HepaRG.

Authors:  Josephin Glück; Marcus Henricsson; Albert Braeuning; Stefanie Hessel-Pras
Journal:  Foods       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.